SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-05-019329
Filing Date
2005-04-29
Accepted
2005-04-29 16:32:22
Documents
7
Period of Report
2005-05-25
Effectiveness Date
2005-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a05-7328_1def14a.htm DEF 14A 897398
2 GRAPHIC g73281ba01image001.gif GRAPHIC 2188
3 GRAPHIC g73281ba01image003.jpg GRAPHIC 3615
4 GRAPHIC g73281ba03image002.jpg GRAPHIC 53312
5 GRAPHIC g73281ba03image004.jpg GRAPHIC 3615
6 GRAPHIC g73281ba03image005.gif GRAPHIC 2188
7 GRAPHIC g73281ba03image007.gif GRAPHIC 14059
  Complete submission text file 0001104659-05-019329.txt   1008639
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 05786455
SIC: 2834 Pharmaceutical Preparations